(4-氨基-1-羟基丁烷-1,1-二基)二磷酸, 99%,T,Alendronic Acid

产品编号:西域试剂-WR366230| CAS NO:66376-36-1| MDL NO:MFCD00868112| 分子式:C4H13NO7P2| 分子量:249.1

Alendronic acid,一种双膦酸盐,是法呢基二磷酸合酶 (FDPS) 抑制剂。Alendronic acid 抑制破骨细胞介导的骨吸收。Alendronic acid 对绝经后骨质疏松症,恶性高钙血症和 Paget 病具有疗效。

本网站销售的所有产品仅用于工业应用或者科学研究等非医疗目的,不可用于人类或动物的临床诊断或者治疗,非药用,非食用,

货号 包装 价格 库存与货期 购买量 操作
西域试剂-WR366230
101.00 杭州 北京(现货)
西域试剂-WR366230
461.00 杭州 北京(现货)

增值税发票√顺丰快递√订货电话:18601927057

英文名称Alendronic Acid
CAS编号66376-36-1
产品描述Alendronic acid,一种双膦酸盐,是法呢基二磷酸合酶 (FDPS) 抑制剂。Alendronic acid 抑制破骨细胞介导的骨吸收。Alendronic acid 对绝经后骨质疏松症,恶性高钙血症和 Paget 病具有疗效。
产品熔点230-235ºC
产品沸点616.7ºC at 760 mmHg
产品密度1.857 g/cm3
产品闪点326.7ºC
精确质量249.01700
PSA180.93000
外观性状白色结晶粉末
溶解性水溶性:不溶
溶解性数据
In Vitro: 

H2O : 3.7 mg/mL (14.85 mM; ultrasonic and warming and heat to 60°C)

配制储备液
浓度 溶剂体积 质量 1 mg 5 mg 10 mg
1 mM 4.0145 mL 20.0723 mL 40.1445 mL
5 mM 0.8029 mL 4.0145 mL 8.0289 mL
10 mM 0.4014 mL 2.0072 mL 4.0145 mL
*

请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效
储备液的保存方式和期限:-80°C, 6 months; -20°C, 1 month。-80°C 储存时,请在 6 个月内使用,-20°C 储存时,请在 1 个月内使用。

In Vivo:

请根据您的实验动物和给药方式选择适当的溶解方案。以下溶解方案都请先按照 In Vitro 方式配制澄清的储备液,再依次添加助溶剂:

——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议您现用现配,当天使用; 以下溶剂前显示的百
分比是指该溶剂在您配制终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶

  • 1.

    请依序添加每种溶剂: PBS

    Solubility: 6.67 mg/mL (26.78 mM); Clear solution; Need ultrasonic and warming and heat to 60°C

*以上所有助溶剂都可在西域网站选购。
体外研究

双膦酸盐广泛应用于骨质疏松症的治疗,其中阿仑膦酸是最常用的处方药。双膦酸盐对骨重塑有强大的抑制作用,这一过程对骨折愈合至关重要【2】。

稳定性

常温常压下稳定,远离氧化剂。

储存条件

存放在密封容器内,并放在阴凉,干燥处。储存的地方必须远离氧化剂。

相关文档

化学品安全说明书(MSDS)

下载MSDS

质检证书(COA)

相关产品


危险品运输编码 1759
RTECS号 SZ6521833
包装等级 III
海关编码 2931900090

Section I.Chemical Product and Company Identification
Chemical Name Alendronic Acid
Portland OR
SynonymPhosphonic acid, P,P'-(4-amino-1-
hydroxybutylidene)bis- (CA INDEX NAME);
4-Amino-1-hydroxybutane-1,1-diphosphonic Acid
Chemical FormulaC4H13NO7P2
CAS Number66376-36-1

Section II.Composition and Information on Ingredients
Toxicology Data
Chemical NameCAS Number Percent (%)TLV/PEL
66376-36-1 Min. 98.0 (T) Not available.Not available.
Alendronic Acid

Section III. Hazards Identification
Acute Health EffectsCorrosive to skin, eyes, and respiratory system. Liquid or spray mist may produce tissue damage, particularly in mucous
membranes of the eyes, mouth and respiratory tract. Skin contact may produce burns. Eye contact can result in corneal
damage or blindness. Inhalation of the spray mist may produce severe irritation of respiratory tract, characterized by
coughing, choking, or shortness of breath. Corrosive materials may cause serious injury if ingested.
Follow safe industrial hygiene practices and always wear proper protective equipment when handling this compound.
Chronic Health EffectsCARCINOGENIC EFFECTS : Not available.
MUTAGENIC EFFECTS : Not available.
TERATOGENIC EFFECTS : Not available.
DEVELOPMENTAL TOXICITY: Reproductive Effects.
Rat TDLo Subcutaneous 2 mg/kg, female 11-20 days of pregnancy
TOXIC Effects:
Specific Developmental Abnormalities - Musculoskeletal system
Repeated exposure of the eyes to a low level of dust can produce eye irritation. Repeated skin exposure can produce
local skin destruction, or dermatitis. Repeated inhalation of dust can produce varying degree of respiratory irritation or
lung damage.

Section IV.First Aid Measures
Eye Contact
Check for and remove any contact lenses. In case of contact, immediately flush eyes with plenty of water for at least 15
minutes. Get medical attention.
Skin ContactIn case of contact, immediately flush skin with plenty of water. Remove contaminated clothing and shoes. Wash clothing
before reuse. Thoroughly clean shoes before reuse. Get medical attention.
InhalationIf the victim is not breathing, perform mouth-to-mouth resuscitation. Loosen tight clothing such as a collar, tie, belt or
waistband. If breathing is difficult, oxygen can be administered. Seek medical attention if respiration problems do not
improve.
IngestionDO NOT INDUCE VOMITING. Loosen tight clothing such as a collar, tie, belt or waistband. If the victim is not breathing,
perform mouth-to-mouth resuscitation. Examine the lips and mouth to ascertain whether the tissues are damaged, a
possible indication that the toxic material was ingested; the absence of such signs, however, is not conclusive.

Section V.Fire and Explosion Data
Not available.
Auto-Ignition
FlammabilityMay be combustible at high temperature.
Flammable Limits
Flash PointsNot available.
Not available.
Combustion ProductsThese products are toxic carbon oxides (CO, CO 2), nitrogen oxides (NO, NO2), phosphates.
Fire Hazards
Not available.
Explosion HazardsRisks of explosion of the product in presence of mechanical impact: Not available.
Risks of explosion of the product in presence of static discharge: Not available.
Continued on Next Page
Alendronic Acid
Fire Fighting Media
SMALL FIRE: Use DRY chemical powder.
and InstructionsLARGE FIRE: Use water spray, fog or foam. DO NOT use water jet.
Consult with local fire authorities before attempting large scale fire-fighting operations.

Section VI.Accidental Release Measures
Spill Cleanup
Corrosive material.
Stop leak if without risk. DO NOT get water inside container. DO NOT touch spilled material. Use water spray to reduce
Instructions
vapors. Prevent entry into sewers, basements or confined areas; dike if needed. Eliminate all sources of ignition.
Consult federal, state, and/or local authorities for assistance on disposal.

Section VII. Handling and Storage
CORROSIVE. Keep container dry. Keep away from heat. Mechanical exhaust required. When not in use, tightly seal the
Handling and Storage
container and store in a dry, cool place. Avoid excessive heat and light. Do not breathe dust. Never add water to this
Information
product. Wear suitable protective clothing. If you feel unwell, seek medical attention and show the label when possible.
Treat symptomatically and supportively.
Always store away from incompatible compounds such as oxidizing agents.

Section VIII. Exposure Controls/Personal Protection
Engineering ControlsUse process enclosures, local exhaust ventilation, or other engineering controls to keep airborne levels below
recommended exposure limits. If user operations generate dust, fume or mist, use ventilation to keep exposure to
airborne contaminants below the exposure limit.
Personal ProtectionFace shield. Lab coat. Dust respirator. Boots. Gloves. A MSHA/NIOSH approved respirator must be used to avoid
inhalation of the product. Suggested protective clothing might not be sufficient; consult a specialist BEFORE handling
this product.
Exposure LimitsNot available.

Section IX. Physical and Chemical Properties
Physical state @ 20°CSolid. (White ~ light yellow, crystal.)Solubility
Not available.
Not available.
Specific Gravity
Molecular Weight249.1Partition Coefficient
Not available.
Boiling PointVapor Pressure
Not available.Not applicable.
Not available.Not available.
Melting PointVapor Density
Refractive IndexNot available.VolatilityNot available.
Critical TemperatureNot available.OdorNot available.
ViscosityNot available.TasteNot available.

Section X.Stability and Reactivity Data
Stability
This material is stable if stored under proper conditions. (See Section VII for instructions)
Conditions of Instability
Avoid excessive heat and light.
Incompatibilities
Reactive with oxidizing agents.

Section XI. Toxicological Information
RTECS NumberSZ6521833
Routes of ExposureEye Contact. Ingestion. Inhalation.
Toxicity DataNot available.
CARCINOGENIC EFFECTS : Not available.
Chronic Toxic Effects
MUTAGENIC EFFECTS : Not available.
TERATOGENIC EFFECTS : Not available.
DEVELOPMENTAL TOXICITY: Reproductive Effects.
Rat TDLo Subcutaneous 2 mg/kg, female 11-20 days of pregnancy
TOXIC Effects:
Specific Developmental Abnormalities - Musculoskeletal system
Repeated exposure of the eyes to a low level of dust can produce eye irritation. Repeated skin exposure can produce
local skin destruction, or dermatitis. Repeated inhalation of dust can produce varying degree of respiratory irritation or
lung damage.
Continued on Next Page
Alendronic Acid
Acute Toxic EffectsCorrosive to skin, eyes, and respiratory system. Liquid or spray mist may produce tissue damage, particularly in mucous
membranes of the eyes, mouth and respiratory tract. Skin contact may produce burns. Eye contact can result in corneal
damage or blindness. Inhalation of the spray mist may produce severe irritation of respiratory tract, characterized by
coughing, choking, or shortness of breath. Corrosive materials may cause serious injury if ingested.
Follow safe industrial hygiene practices and always wear proper protective equipment when handling this compound.

Section XII.Ecological Information
EcotoxicityNot available.
Environmental FateNot available.

Section XIII. Disposal Considerations
Recycle to process, if possible. Consult your local regional authorities. You may be able to dissolve or mix material with a
Waste Disposal
combustible solvent and burn in a chemical incinerator equipped with an afterburner and scrubber system. Observe all
federal, state and local regulations when disposing of the substance.

Section XIV. Transport Information
DOT Classification
DOT Class 8: Corrosive material
PIN Number
Proper Shipping Name
Corrosive solid, n.o.s.
Packing Group (PG)III
DOT Pictograms

Section XV. Other Regulatory Information and Pictograms
TSCA Chemical InventoryThis product is NOT on the EPA Toxic Substances Control Act (TSCA) inventory. The following notices are required by 40
CFR 720.36 (C) for those products not on the inventory list:
(EPA)
(i) These products are supplied solely for use in research and development by or under the supervision of a technically
qualified individual as defined in 40 CFR 720.0 et sec.
(ii) The health risks of these products have not been fully determined. Any information that is or becomes available will be
supplied on an MSDS sheet.
WHMIS Classification
CLASS E: Corrosive solid.
(Canada)
EINECS Number (EEC) Not available.
EEC Risk Statements
R34- Causes burns.


SECTION 16 - ADDITIONAL INFORMATION
N/A

~92%

66376-36-1结构式

66376-36-1

文献:ORCHID CHEMICALS and PHARMACEUTICALS LTD. Patent: US2007/66569 A1, 2007 ; Location in patent: Page/Page column 2 ;

~83%

66376-36-1结构式

66376-36-1

文献:Guenin, Erwann; Monteil, Maelle; Bouchemal, Nadia; Prange, Thierry; Lecouvey, Marc European Journal of Organic Chemistry, 2007 , # 20 p. 3380 - 3391

~59%

66376-36-1结构式

66376-36-1

文献:Guenin, Erwann; Monteil, Maelle; Bouchemal, Nadia; Prange, Thierry; Lecouvey, Marc European Journal of Organic Chemistry, 2007 , # 20 p. 3380 - 3391

~%

66376-36-1结构式

66376-36-1

文献:WO2005/47282 A1, ; Page/Page column 8 ;

~70%

66376-36-1结构式

66376-36-1

文献:Xu, Guangyu; Xie, Yuyuan; Wu, Xihan Organic Preparations and Procedures International, 2004 , vol. 36, # 2 p. 185 - 187

~%

66376-36-1结构式

66376-36-1

文献:Phosphorus, Sulfur and Silicon and the Related Elements, , vol. 63, # 1/2 p. 181 - 192

~%

66376-36-1结构式

66376-36-1

文献:Phosphorus, Sulfur and Silicon and Related Elements, , vol. 129, p. 99 - 110

服务热线

13911702513
18601927057

微信客服